Access the full text.
Sign up today, get DeepDyve free for 14 days.
E. Ryberg, N. Larsson, S. Sjögren, S. Hjorth, Nils-Olov Hermansson, J. Leonova, T. Elebring, K. Nilsson, T. Drmota, P. Greasley (2007)
The orphan receptor GPR55 is a novel cannabinoid receptorBritish Journal of Pharmacology, 152
G. Paxinos, Charles Watson (1983)
The Rat Brain in Stereotaxic Coordinates
F. Moreira, D. Aguiar, F. Guimarães (2007)
Anxiolytic-like effect of cannabinoids injected into the rat dorsolateral periaqueductal grayNeuropharmacology, 52
R. Corradetti, B. Mlinar, Chiara Falsini, A. Pugliese, A. Cilia, C. Destefani, R. Testa (2005)
Differential Effects of the 5-Hydroxytryptamine (5-HT)1A Receptor Inverse Agonists Rec 27/0224 and Rec 27/0074 on Electrophysiological Responses to 5-HT1A Receptor Activation in Rat Dorsal Raphe Nucleus and Hippocampus in VitroJournal of Pharmacology and Experimental Therapeutics, 315
A. Malfait, R. Gallily, P. Sumariwalla, A. Malik, E. Andreakos, R. Mechoulam, M. Feldmann (2000)
The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis.Proceedings of the National Academy of Sciences of the United States of America, 97 17
F. D'amour, Donn Smith (1941)
A METHOD FOR DETERMINING LOSS OF PAIN SENSATIONJournal of Pharmacology and Experimental Therapeutics, 72
J. Elliott, D. Heal, C. Mardens (1993)
Experimental Approaches to Anxiety and DepressionBehavioural Pharmacology, 4
M. Molchanov, F. Guimarães (2002)
Anxiolytic-like effects of AP7 injected into the dorsolateral or ventrolateral columns of the periaqueductal gray of ratsPsychopharmacology, 160
NW Pedigo, WL Dewey, LS Harris (1975)
Determination and characterization of the antinociceptive activity of intraventricularly administered acetylcholine in miceJ Pharmacol Exp Ther, 193
I. Geller, J. Kułak, J. Seifter (1962)
The effects of chlordiazepoxide and chlorpromazine on a punishment discriminationPsychopharmacologia, 3
L. Resstel, S. Joca, F. Moreira, F. Corrěa, F. Guimarães (2006)
Effects of cannabidiol and diazepam on behavioral and cardiovascular responses induced by contextual conditioned fear in ratsBehavioural Brain Research, 172
R. Mechoulam, Y. Gaoni (1965)
Hashish. IV. The isolation and structure of cannabinolic cannabidiolic and cannabigerolic acids.Tetrahedron, 21 5
R. Nogueira, F. Graeff (1995)
Role of 5-HT receptor subtypes in the modulation of dorsal periaqueductal gray generated aversionPharmacology Biochemistry and Behavior, 52
E. Carlini, JoséRoberto Leite, M. Tannhauser, A. Berardi (1973)
Cannabidiol and Cannabis sativa extract protect mice and rats against convulsive agentsJournal of Pharmacy and Pharmacology, 25
J. Zanoveli, R. Nogueira, H. Zangrossi (2003)
Serotonin in the dorsal periaqueductal gray modulates inhibitory avoidance and one-way escape behaviors in the elevated T-maze.European journal of pharmacology, 473 2-3
Ángeles Pérez-Padilla, R. Pellón (2007)
Behavioural and pharmacological specificity of the effects of drugs on punished schedule-induced polydipsiaBehavioural Pharmacology, 18
V. Soares, H. Zangrossi (2004)
Involvement of 5-HT1A and 5-HT2 receptors of the dorsal periaqueductal gray in the regulation of the defensive behaviors generated by the elevated T-mazeBrain Research Bulletin, 64
A. Zuardi, S. Morais, F. Guimarães, R. Mechoulam (1995)
Antipsychotic effect of cannabidiol.The Journal of clinical psychiatry, 56 10
A. Carobrez, L. Bertoglio (2005)
Ethological and temporal analyses of anxiety-like behavior: The elevated plus-maze model 20 years onNeuroscience & Biobehavioral Reviews, 29
T. Bisogno, L. Hanuš, L. Petrocellis, S. Tchilibon, D. Ponde, I. Brandi, A. Moriello, John Davis, R. Mechoulam, V. Marzo (2001)
Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamideBritish Journal of Pharmacology, 134
E. Carrier, J. Auchampach, C. Hillard (2006)
Inhibition of an equilibrative nucleoside transporter by cannabidiol: A mechanism of cannabinoid immunosuppression, 103
F. Guimarães, T. Chiaretti, F. Graeff, A. Zuardi (2005)
Antianxiety effect of cannabidiol in the elevated plus-mazePsychopharmacology, 100
Ethan Russo, G. Guy (2006)
A tale of two cannabinoids: the therapeutic rationale for combining tetrahydrocannabinol and cannabidiol.Medical hypotheses, 66 2
E. Palazzo, V. Novellis, I. Marabese, D. Cuomo, F. Rossi, L. Berrino, F. Rossi, S. Maione (2002)
Interaction between vanilloid and glutamate receptors in the central modulation of nociception.European journal of pharmacology, 439 1-3
R. Bandler, K. Keay, Nicole Floyd, Joseph Price (2000)
Central circuits mediating patterned autonomic activity during active vs. passive emotional copingBrain Research Bulletin, 53
V. Beijamini, F. Guimarães (2006)
c-Fos expression increase in NADPH-diaphorase positive neurons after exposure to a live catBehavioural Brain Research, 170
M. Millan (2003)
The neurobiology and control of anxious statesProgress in Neurobiology, 70
K. Mishima, K. Hayakawa, K. Abe, T. Ikeda, N. Egashira, K. Iwasaki, M. Fujiwara (2005)
Cannabidiol Prevents Cerebral Infarction Via a Serotonergic 5-Hydroxytryptamine1A Receptor–Dependent MechanismStroke, 36
R. Pertwee (2005)
Inverse agonism and neutral antagonism at cannabinoid CB1 receptors.Life sciences, 76 12
J. Raymond, Y. Mukhin, T. Gettys, M. Garnovskaya (1999)
The recombinant 5‐HT1A receptor: G protein coupling and signalling pathwaysBritish Journal of Pharmacology, 127
(1992)
Behavioural detection of anxiolytic action
T. Rubino, N. Realini, Chiara Castiglioni, C. Guidali, D. Vigano', E. Marras, S. Petrosino, G. Perletti, M. Maccarrone, V. Marzo, D. Parolaro (2008)
Role in anxiety behavior of the endocannabinoid system in the prefrontal cortex.Cerebral cortex, 18 6
J. Vogel, B. Beer, D. Clody (2004)
A simple and reliable conflict procedure for testing anti-anxiety agentsPsychopharmacologia, 21
A. Hohmann, R. Suplita, Nathan Bolton, M. Neely, D. Fegley, R. Mangieri, Jocelyn Krey, J. Walker, P. Holmes, J. Crystal, A. Duranti, A. Tontini, M. Mor, G. Tarzia, D. Piomelli (2005)
An endocannabinoid mechanism for stress-induced analgesiaNature, 435
A. Zuardi, E. Finkelfarb, Bueno Of, Musty Re, I. Karniol (1981)
Characteristics of the stimulus produced by the mixture of cannabidiol with delta 9-tetrahydrocannabinol.Archives internationales de pharmacodynamie et de therapie, 249 1
M. Hamon, L. Lanfumey, S. Mestikawy, C. Boni, M. Miquel, F. Bolaños, L. Schechter, H. Gozlan (1990)
The main features of central 5-HT1 receptors.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 3 5-6
E. Russo, Andrea Burnett, B. Hall, K. Parker (2005)
Agonistic Properties of Cannabidiol at 5-HT1a ReceptorsNeurochemical Research, 30
W. Devane, F. Dysarz, M. Johnson, L. Melvin, A. Howlett (1988)
Determination and characterization of a cannabinoid receptor in rat brain.Molecular pharmacology, 34 5
F. Moreira, F. Guimarães (2005)
Cannabidiol inhibits the hyperlocomotion induced by psychotomimetic drugs in mice.European journal of pharmacology, 512 2-3
F. Moreira, D. Aguiar, F. Guimarães (2006)
Anxiolytic-like effect of cannabidiol in the rat Vogel conflict testProgress in Neuro-Psychopharmacology and Biological Psychiatry, 30
A. Thomas, G. Baillie, A. Phillips, R. Razdan, R. Ross, R. Pertwee (2007)
Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitroBritish Journal of Pharmacology, 150
ShokeiKim‐Mitsuyama, EiichiroYamamoto, TomokoTanaka, YumeiZhan, YasukatsuIzumi, YasuhiroIzumiya, TakeshiIoroi, HidekiWanibuchi, HiroshiIwao (2005)
Critical Role of Angiotensin II in Excess Salt-Induced Brain Oxidative Stress of Stroke-Prone Spontaneously Hypertensive RatsStroke
M. Herkenham, Abigail Lynn, M.Ross Johnson, L. Melvin, B. Costa, K. Rice (1991)
Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study, 11
L. Cristino, L. Petrocellis, G. Pryce, D. Baker, V. Guglielmotti, V. Marzo (2006)
Immunohistochemical localization of cannabinoid type 1 and vanilloid transient receptor potential vanilloid type 1 receptors in the mouse brainNeuroscience, 139
G. Carrasco, L. Kar (2003)
Neuroendocrine pharmacology of stress.European journal of pharmacology, 463 1-3
These results suggest the CBD interacts with 5HT1A receptors to produce anxiolytic effects in the dlPAG.
Psychopharmacology – Springer Journals
Published: Aug 1, 2008
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.